- Home
- PHR
PHR
Phreesia Inc.
as 11-01-2025 4:26am EST
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.4B | IPO Year: | 2019 |
| Target Price: | $33.73 | AVG Volume (30 days): | 575.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.07 - $32.76 | Next Earning Date: | 12-08-2025 |
| Revenue: | $449,672,000 | Revenue Growth: | 15.31% |
| Revenue Growth (this year): | 14.98% | Revenue Growth (next year): | 12.12% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Oct 17 '25 | Sell | $22.36 | 639 | $14,288.81 | 111,840 | |
| Roberts Evan | PHR | President, Provider Solutions | Oct 17 '25 | Sell | $22.36 | 1,888 | $42,217.95 | 724,949 | |
| Linetsky David | PHR | President, Network Solutions | Oct 17 '25 | Sell | $22.36 | 2,059 | $46,041.71 | 171,829 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Oct 17 '25 | Sell | $22.36 | 1,241 | $27,750.25 | 135,737 | |
| Indig Chaim | PHR | Chief Executive Officer | Oct 17 '25 | Sell | $22.36 | 3,163 | $70,728.48 | 1,252,608 | |
| Gandhi Balaji | PHR | Chief Financial Officer | Oct 17 '25 | Sell | $22.36 | 885 | $19,789.66 | 98,240 | |
| Hui Yvonne | PHR | Principal Accounting Officer | Oct 15 '25 | Sell | $23.05 | 302 | $6,960.50 | 30,336 | |
| Linetsky David | PHR | President, Network Solutions | Sep 18 '25 | Sell | $23.94 | 93 | $2,226.30 | 171,829 | |
| Linetsky David | PHR | President, Network Solutions | Sep 17 '25 | Sell | $23.50 | 1,064 | $25,004.00 | 171,829 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Sep 17 '25 | Sell | $23.50 | 2,059 | $48,386.50 | 135,737 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
Business Wire
25 days ago
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Business Wire
a month ago
Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies
Simply Wall St.
2 months ago
Phreesia Second Quarter 2026 Earnings: EPS Beats Expectations
GuruFocus.com
2 months ago
Phreesia Inc (PHR) Q2 2026 Earnings Call Highlights: Record Revenue and First Positive Net Income
Motley Fool
2 months ago
Phreesia PHR Q2 2026 Earnings Call Transcript
Zacks
2 months ago
Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks
2 months ago
Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates
Associated Press Finance
2 months ago
Phreesia: Fiscal Q2 Earnings Snapshot
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.